Infliximab desensitization in patients with Inflammatory Bowel Diseases: a safe therapeutic alternative

被引：0
|
作者：
Hammoudi, N. [1 ]
Hassid, D. [1 ]
Bonnet, J. [1 ]
Minh, M. L. Tran [1 ]
Baudry, C. [1 ]
Chedouba, L. [1 ]
Vauthier, A. [1 ]
Gornet, J. M. [1 ]
Allez, M. [1 ]
机构：
[1] APHP St Louis, Gastroenterol, Paris, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P515
引用
收藏
页码：643 / 643
页数：1
相关论文
共 50 条
  • [41] Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 369 - 370
  • [42] Intermittent Appearance of Antibodies to Infliximab Is Not Associated With Reduced Efficacy in Patients With Inflammatory Bowel Diseases
    Awadie, Halim
    Waterman, Matti
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (01) : E47 - E51
  • [43] Accurate and rapid microfluidic ELISA to monitor Infliximab titers in patients with inflammatory bowel diseases
    Iria, Ines
    Soares, Ruben R. G.
    Bras, Eduardo J. S.
    Chu, Virginia
    Goncalves, Joao
    Conde, Joao P.
    ANALYST, 2022, 147 (03) : 480 - 488
  • [44] Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases
    Cocco, Andrea
    Angelucci, Erika
    Viscido, Angelo
    Caprilli, Renzo
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (10) : 1317 - 1319
  • [45] Infliximab pharmacokinetics in inflammatory Bowel disease patients
    Ternant, David
    Aubourg, Alexandre
    Magdelaine-Beuzelin, Charlotte
    Degenne, Danielle
    Watier, Herve
    Picon, Laurence
    Paintaud, Gilles
    THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 523 - 529
  • [46] Oral infliximab nanomedicines for targeted treatment of inflammatory bowel diseases
    Mohan, Lauren J.
    Daly, Jacqueline S.
    Ryan, Barbara M.
    Ramtoola, Zebunnissa
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 183
  • [47] Usefulness of therapeutic monitoring of infliximab in the treatment of inflammatory bowel disease
    Quera, Rodrigo
    Moreno, Mauricio
    Simian, Daniela
    Ibanez, Patricio
    Lubascher, Jaime
    Figueroa, Carolina
    Flores, Lilian
    Kronberg, Udo
    Pizarro, Gonzalo
    Fluxa, Daniela
    REVISTA MEDICA DE CHILE, 2018, 146 (11) : 1241 - 1251
  • [48] Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review
    Radin, Massimo
    Sciascia, Savino
    Roccatello, Dario
    Cuadrado, Maria Jose
    BIODRUGS, 2017, 31 (01) : 37 - 49
  • [49] Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review
    Massimo Radin
    Savino Sciascia
    Dario Roccatello
    Maria Jose Cuadrado
    BioDrugs, 2017, 31 : 37 - 49
  • [50] A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
    Miehsler, W.
    Novacek, G.
    Wenzl, H.
    Vogelsang, H.
    Knoflach, P.
    Kaser, A.
    Dejaco, C.
    Petritsch, W.
    Kapitan, M.
    Maier, H.
    Graninger, W.
    Tilg, H.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2010, 4 (03): : 221 - 256
12345